Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

434
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
434
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

391
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
391
Renal Corpuscle01:20

Renal Corpuscle

1.6K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.6K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishing a core outcome measure for cancer in trials in kidney transplantation: a standardized outcomes in nephrology-kidney transplantation consensus workshop report.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

AKI After Hepatic Histotripsy.

Kidney international reports·2026
Same author

Phosphate Disorders in Cancer.

Kidney360·2026
Same author

Deceased Donor Kidney Transplantation Versus Continued Dialysis Among Patients Aged 75 Years or Older: A Target Trial Emulation.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Ten tips on how to prevent and manage post-transplant lymphoproliferative disease in kidney transplant recipients.

Clinical kidney journal·2026
Same author

Enteric and Controlled-Release Budesonide in IgA Nephropathy: Expanding Access While Refining Evidence.

Kidney international reports·2026

Related Experiment Video

Updated: Jun 3, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.8K

The Difficulties of Treating Complement-3-Mediated Glomerulopathy.

Maham Ghani1, Bedir Alisan2, Daniel Barmas-Alamdari3

  • 1Northwell, New Hyde Park, NY, Department of Medicine, Manhasset, NY.

American Journal of Therapeutics
|January 10, 2025
PubMed
Summary

C3 glomerulopathy (C3G) is a rare kidney disease involving complement alternative pathway dysregulation. Further research is needed to understand its causes, improve diagnosis, and develop effective treatments for this complex condition.

More Related Videos

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
10:05

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures

Published on: March 18, 2021

6.8K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.2K

Related Experiment Videos

Last Updated: Jun 3, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.8K
A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
10:05

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures

Published on: March 18, 2021

6.8K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.2K

Area of Science:

  • Nephrology
  • Immunology
  • Complement System Biology

Background:

  • C3 glomerulopathy (C3G) is a rare renal disease characterized by complement alternative pathway dysregulation.
  • It encompasses dense deposit disease and C3 glomerulonephritis, with distinct age demographics.
  • Low incidence in the US (1-3 cases/1,000,000) highlights its rarity.

Purpose of the Study:

  • To review the current understanding of C3 glomerulopathy (C3G) etiology and pathophysiology.
  • To evaluate diagnostic challenges and the clinical utility of biomarkers.
  • To summarize existing and emerging therapeutic strategies for C3G.

Main Methods:

  • Review of existing literature on C3 glomerulopathy.
  • Analysis of diagnostic workups including complement assays, autoantibody panels, and kidney biopsy.
  • Examination of current and investigational treatment modalities.

Main Results:

  • Etiology and pathophysiology of C3G remain incompletely understood, with unclear biomarker roles.
  • Kidney biopsy is the definitive diagnostic tool, but sensitivity/specificity challenges exist.
  • Therapies range from supportive care to eculizumab, with ongoing trials for complement inhibitors.

Conclusions:

  • C3 glomerulopathy management is complex, requiring further research into its fundamental mechanisms.
  • Large-scale clinical trials are essential for validating diagnostic tools and therapeutic interventions.
  • Continued investigation into C3G etiology and pathophysiology is crucial for advancing patient care.